<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>996f4a58-b782-45d2-80a3-b82158622816</id>
  <name>Therapeutic Anticoagulation - COVID-19 Adult Order Group</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ï»© Technical Traceability</key>
        <value>{~AHSID~996f4a58-b782-45d2-80a3-b82158622816~NAME~Therapeutic Anticoagulation - COVID-19 Adult Order Group}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Patients admitted who are NOT critically ill (up to 15L/min O2, not on HHHFO, ward based), who are at low bleeding risk (HASBLED score less than or equal to 2), and who are not pregnant,&amp;nbsp; should be considered for &lt;strong&gt;therapeutic anticoagulation&lt;/strong&gt;.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;In patients who are not candidates for therapeutic anticoagulation, use &lt;strong&gt;pharmacological prophylaxis&lt;/strong&gt; (low molecular-weight heparin preferred) unless contraindicated, and continue until hospital discharge (see &lt;em&gt;VTE Prophylaxis - COVID-19, Adult order &lt;/em&gt;panel)&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:602px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:205px&quot;&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;strong&gt;COVID-19 Population&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;(includes immuno-compromised and Hospital-acquired)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:394px&quot;&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;strong&gt;&amp;nbsp;VTE Prophylaxis dosing&amp;nbsp;or Therapeutic Anticoagulation dosing&amp;nbsp;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;(NOTE: therapeutic dosing is for 14 days or until discharge)&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:205px&quot;&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;strong&gt;Severe &amp;nbsp;&lt;/strong&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;Up to 15 L/min O2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:394px&quot;&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;Weight-based &lt;strong&gt;therapeutic dose &lt;/strong&gt;tinzaparin if low bleeding risk if:&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;-low bleeding risk (HAS-BLED less than or equal to 2)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;-not pregnant&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;OR&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;Weight based &lt;strong&gt;prophylaxis&lt;/strong&gt; dose tinzaparin if higher bleeding risk (HAS-BLED greater than 2)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:205px&quot;&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;strong&gt;Critically Ill&amp;nbsp;&amp;nbsp;&lt;/strong&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;Over 15 L/min O2 (consider patients also on HHHFO or NIV)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:394px&quot;&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Weight-based prophylaxis dose tinzaparin&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Continue therapeutic dose tinzaparin if started in hospital and patient becomes critically ill.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;strong&gt;- Score: HAS-BLED&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;em&gt;https://ahsweb.ca/HEE/MD_Calc_HAS-BLED_score&lt;/em&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;color:#c0392b&quot;&gt;- PLACEHOLDER - Guidance: link to further AHS guidance&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Where once daily dosing is appropriate, use tinzaparin subcutaneously once daily for general VTE treatment, cancer associated thrombosis, pregnancy, major trauma, or obesity.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;strong&gt;Weight-Band Dosing for Therapeutic&amp;nbsp;Subcutaneous Tinzaparin&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;u&gt;No Weight Documented&lt;/u&gt;:&amp;nbsp;Please close this order and enter a weight on this patient so that the correct dosage will populate. &amp;nbsp;Alternatively, use the dosing chart to determine the appropriate dose.&lt;/p&gt;&lt;p&gt;&lt;u&gt;Weight Documented&lt;/u&gt;: The system will choose the appropriate weight based on the table below.&lt;/p&gt;&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:670px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Weight Band &lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient Actual Body Weight (kg)&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;&lt;strong&gt;Tinzaparin Dosing&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;Less than 40 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;175 units/kg SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;40 to 43 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;7000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;43.1 to 48 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;8000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;48.1 to 54 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;9000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;54.1 to 63 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;10,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;63.1 to 74 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;12,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;74.1 to 86 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;14,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;86.1 to 97 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;16,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;97.1 to 109 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;18,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;109.1 to 126 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;20,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;126.1 to 133 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;24,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;133.1 to 148 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;24,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;148.1 to 171 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;28,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;171.1 to 177 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;32,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;177.1 to 195 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;32,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;195.1 to 218 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;36,000 units SUBCUTANEOUSLY&amp;nbsp;once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;218.1 to 228 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;36,000 units SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;width:227px&quot;&gt;Greater than 228 kg&lt;/td&gt;&lt;td style=&quot;width:440px&quot;&gt;175 units/kg SUBCUTANEOUSLY once daily&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Tinzaparin for weights 40 kg - 228 kg&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Tinzaparin for weights 40 kg - 228 kg&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Patient clot risk, bleed risk and renal function must also be assessed to determine appropriateness of applying weight-based band dosing.&lt;br&gt;&amp;nbsp;&lt;br&gt;Dose Band for CrCl 20 mL per minute or greater and weight 40 kg to 228 kg only.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Tinzaparin for weights under 40 kg or greater than 228 kg&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Therapeutic Anticoagulation - COVID-19 Adult Order Group">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Therapeutic Anticoagulation">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Tinzaparin for weights 40 kg - 228 kg">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; ______ SC daily at bedtime, Stop After 14 Days"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="_"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Tinzaparin for weights under 40 kg or greater than 228 kg">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; (175 units/kg/dose) ______ units SC daily at bedtime, Stop After 14 Days"/>
      </Item>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
</template>